Song Jun Hui, Hwang Byungdoo, Chung Hyun Joo, Moon BoKyung, Kim Jin Wook, Ko Kisung, Kim Bae Whan, Kim Won Ryong, Kim Wun Jae, Myung Soon Chul, Moon Sung Kwon
Department of Food and Nutrition, College of Biotechnology and Natural Resources, Chung-Ang University, Anseong, Korea.
Department of Urology, Chung-Ang University College of Medicine, Seoul, Korea.
World J Mens Health. 2020 Jul;38(3):385-396. doi: 10.5534/wjmh.190173. Epub 2020 Mar 19.
In this study, we tested whether the resveratrol-enriched peanut sprout extracts cultivated with fermented sawdust medium (PSEFS) could suppress benign prostatic hyperplasia (BPH) and .
The mode of action of PSEFS was estimated by employing high-performance liquid chromatography analysis, MTT assay, cell counting, cell cycle analysis, immunoblots, and immunoprecipitation and electrophoretic mobility shift assay. efficacy of PSEFS was analyzed in BPH animal model immunostaining and enzyme-linked immunosorbent assay.
We selected the peanut sprout variety, which contains the highest level of resveratrol. The resveratrol levels in PSEFS were higher than those obtained with hydroponic technology. PSEFS treatment induced cell cycle arrest at the G1-phase by downregulating CDK4 and cyclin D1 p21WAF1 induction in the RWPE-1 and WPMY prostate cells, thereby decreasing their proliferation. Treatment with PSEFS decreased ERK1/2 phosphorylation and increased JNK phosphorylation. The levels of DNA-bound transcription factors associated with proliferation (nuclear factor-κB, Sp-1, and AP-1) decreased upon PSEFS treatment in both prostate cells. Additionally, the levels of the molecular markers of BPH development (5α-reductase, androgen receptor, fibroblast growth factor, Bcl-2, and Bax) also changed by the addition of PSEFS. Finally, in a testosterone propionate-induced BPH model in rats, PSEFS administration attenuated the size, weight, and thickness of prostate tissues with no signs of death.
These results showed that PSEFS inhibited BPH both and and might be useful in the development of a potential BPH therapy.
在本研究中,我们测试了用发酵锯末培养基培养的富含白藜芦醇的花生芽提取物(PSEFS)是否能抑制良性前列腺增生(BPH)。
通过高效液相色谱分析、MTT 法、细胞计数、细胞周期分析、免疫印迹、免疫沉淀和电泳迁移率变动分析来评估 PSEFS 的作用模式。通过免疫染色和酶联免疫吸附测定在 BPH 动物模型中分析 PSEFS 的疗效。
我们选择了白藜芦醇含量最高的花生芽品种。PSEFS 中的白藜芦醇水平高于水培技术获得的水平。PSEFS 处理通过下调 RWPE-1 和 WPMY 前列腺细胞中的 CDK4 和细胞周期蛋白 D1 以及诱导 p21WAF1,使细胞周期停滞在 G1 期,从而降低其增殖。PSEFS 处理降低了 ERK1/2 磷酸化并增加了 JNK 磷酸化。在两种前列腺细胞中,PSEFS 处理后与增殖相关的 DNA 结合转录因子(核因子-κB、Sp-1 和 AP-1)水平降低。此外,添加 PSEFS 也改变了 BPH 发展的分子标志物(5α-还原酶、雄激素受体、成纤维细胞生长因子、Bcl-2 和 Bax)的水平。最后,在丙酸睾酮诱导的大鼠 BPH 模型中,给予 PSEFS 可减轻前列腺组织的大小、重量和厚度,且无死亡迹象。
这些结果表明,PSEFS 在体内和体外均能抑制 BPH,可能有助于开发潜在的 BPH 治疗方法。